Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-04-04

FDA Approved: OLOPATADINE HYDROCHLORIDE — Original Application (Allwell Health Inc)

View source ↗

Summary

FDA approves Allwell Health Inc's original application for olopatadine hydrochloride, a generic antihistamine for allergic conjunctivitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OLOPATADINE HYDROCHLORIDE (olopatadine hydrochloride)

Snippet

ORIG AP for OLOPATADINE HYDROCHLORIDE (OLOPATADINE HYDROCHLORIDE)